Roivant Sciences Ltd (ROIV)

Working capital turnover

		Mar 31, 2025	Mar 31, 2024	Mar 31, 2023	Mar 31, 2022	Mar 31, 2021
Revenue	US$ in thousands	29,053	124,795	61,280	55,286	23,795
Total current assets	US$ in thousands	5,000,060	6,731,830	1,798,590	2,146,520	2,187,000
Total current liabilities	US$ in thousands	149,411	266,758	272,448	184,367	218,961
Working capital turnover		0.01	0.02	0.04	0.03	0.01

March 31, 2025 calculation

Working capital turnover = Revenue ÷ (Total current assets – Total current liabilities)
= $29,053K ÷ ($5,000,060K – $149,411K)
= 0.01

The working capital turnover ratio for Roivant Sciences Ltd has shown a fluctuating trend over the past five years. In March 2021, the ratio was at 0.01, indicating that the company generated $0.01 in revenue for every $1 of working capital invested.

There was a notable improvement in performance in March 2022, with the ratio increasing to 0.03. This suggests that for every $1 of working capital, the company generated $0.03 in revenue.

The trend continued to improve in March 2023, reaching a ratio of 0.04. This indicates that the company's efficiency in utilizing its working capital to generate revenue increased further.

However, there was a slight decline in performance in March 2024, with the ratio dropping to 0.02. This may be a signal of potential challenges in managing working capital effectively during that period.

The data for March 31, 2025 is missing (indicated by a dash), making it difficult to assess the most recent performance. It is important for the company to monitor and manage its working capital turnover continuously to ensure efficient utilization of resources and sustainable growth in the future.